Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
James Strainic, MD

James Strainic, MD

  • Assistant Professor, CWRU School of Medicine
  • Specialty: Pediatric Cardiology
  • Location:
    UH Landerbrook Health Center
    5850 Landerbrook Dr
    Mayfield Heights, OH 44124

Biography: James Strainic, MD


  • Congenital Heart Disease
  • Connective Tissue Disease in Children
  • Echocardiography
  • Fetal Echocardiography
  • Pediatric Cardiology
  • Pediatric Exercise Physiology
  • Three Dimensional Echocardiography
  • Transesophageal Echocardiography


Fellowship | Pediatric Cardiology
Pediatric Cardiology - Uh Case Medical Center (2006 - 2009)

Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - University Hospitals Of Cleveland (2005 - 2006)

Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (2002 - 2005)

Medical Education
University Of Cincinnati College Of Medicine (1998 - 2002)

Xavier University (1998)


James Strainic, MD, is a pediatric cardiologist and director of the Fetal Heart Program in the Congenital Heart and Director of Pediatric Cardiology Outpatient Services at the Congenital Heart Collaborative at University Hospitals Rainbow Babies & Children’s Hospital.

As director of the Fetal Heart Program, Dr. Strainic oversees all aspects of maternal-fetal cardiology care at UH Rainbow Babies & Children’s Hospital. The fetal heart center offers fetal cardiology diagnostic imaging and fetal cardiac intervention. The fetal cardiac intervention team is a 12-member team, representing obstetrics & gynecology, maternal fetal medicine, pediatric cardiology, pediatric interventional cardiology, pediatric anesthesia, OB anesthesia from UH Rainbow, Nationwide Children’s Hospital and MacDonald Women’s Hospital, that performs fetal aortic valvuloplasty. This fetal heart program is the only one in Ohio to offer fetal aortic valvuloplasty and one of only in 10 in the nation. The team provides advanced care locally in north east Ohio and internationally with patients coming as far as the United Arab Emirates.

Critical to infants with developing congenital heart disease, fetal aortic valvuloplasty is a unique procedure that uses ultrasound guidance and a catheter-based approach to gain access to the fetal heart, subsequently opening the aortic valve using a tiny, inflated balloon. This increases blood flow through the left ventricle of the heart to help its development and prevent the progression of hypoplastic left heart syndrome (HLHS). The goal of the minimally invasive fetal procedure is to attempt to reverse the developing HLHS and decrease the number of open heart surgeries for the child later in life – or eliminate them entirely.

Dr. Strainic is also an assistant professor at Case Western Reserve University School of Medicine. He earned his undergraduate degree in natural sciences at Xavier University in Cincinnati and his medical degree at University of Cincinnati College of Medicine. He completed his residency training in pediatrics and fellowship training in pediatric cardiology at UH Rainbow Babies & Children’s Hospital.

Dr. Strainic is active in the field of pediatric cardiology research. His published work includes peer-reviewed journal articles, abstracts and book chapters and he has presented at international, national and regional medical conferences and meetings.

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, James Strainic did not disclose any Outside Relationships with Industry.